Aspen Pharmacare HL-Unsp ADRAPNHY
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$6.79avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Aspen Pharmacare HL-Unsp ADR (APNHY) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was Rhumbline Advisers ($7K).
- Company
- Aspen Pharmacare HL-Unsp ADR
- CUSIP
- 04530Y106
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 230 shares bought, net +230 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Add +27.5% | 1,065 | $7K |
"% of holder's portfolio" is APNHY's weight in each manager's 13F, not the share of Aspen Pharmacare HL-Unsp ADR the manager owns.